The largest database of trusted experimental protocols
> Chemicals & Drugs > Organic Chemical > Mifepristone

Mifepristone

Mifepristone is a synthetic steroid compound that acts as an antiprogesterone agent.
It is used for the termination of early pregnancy, as well as for other medical applications such as the treatment of Cushing's syndrome.
Mifepristone binds to the progesterone receptor and blocks the action of the natural hormone progesterone, resulting in the disruption of early pregnancy development.
Expeience the power of PubCompare.ai today to optimize your Mifepristone research and identify the best protocols and products for enhanced reproducibility and accuracy.

Most cited protocols related to «Mifepristone»

The immortalized erythroid progenitor cell lines were induced to differentiate into more mature erythroid cells by culture in erythroid differentiation medium; IMDM (Sigma) containing 10% human AB serum (Kohjin Bio, Saitama, Japan or TAKARA BIO), α-tocopherol (20 ng/ml; Sigma), linoleic acid (4 ng/ml; Sigma), cholesterol (200 ng/ml; Sigma), sodium selenite (2 ng/ml; Sigma), holo-transferrin (200 µg/ml; Sigma), human insulin (10 µg/ml; Sigma), ethanolamine (10 µM; Sigma), 2-ME (0.1 mM; Sigma), D-mannitol (14.57 mg/ml; Sigma), mifepristone (an antagonist of glucocorticoid receptor, 1 µM; Sigma) and EPO (5 IU/ml).
Full text: Click here
Publication 2013
alpha-Tocopherol Cell Lines Cholesterol Culture Media Erythroid Cells Ethanolamines Homo sapiens Insulin Linoleic Acid Mannitol Mifepristone NR3C1 protein, human Selenite, Sodium Serum Transferrin

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2008
Adult Agar Antifungal Agents Biological Assay Diptera Drosophila Escherichia coli Ethanol Females Food Furuncles Genes Glucose Males Mifepristone Pharmaceutical Preparations propionic acid Psychological Inhibition R-38486 Solvents Wounds and Injuries Yeast, Dried

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2010
Animals Epistropheus Human Body Mifepristone Movement Plexiglas Visually Impaired Persons

Drosophila strains.
All the target transgenes
for over-expression (Table 1) were obtained from Bloomington Drosophila Stock Center. The ubiquitous Geneswitch driver lines Act-GS-255B and
Act-GS-255A contain multiple copies of a P element construct in which
expression of the Geneswitch cDNA is under the control of the tissue-general Actin5C promoter [16 (link)]. The UAS-ultraGFP strain contain multiple copies of a UAS-eGFP
construct, and its construction and characterization have been recently
described [18 ]. The Geneswitch system drivers Elav-GS, MHC-GS, S1-32
and S1-106 were generously provided by T. Osterwalder and R. Davis
[19 (link),20 (link)].


Drosophila culture.
Drosophila culture and life span assays were performed as described previously [16 (link)].
GeneSwitch virgins were used in the crosses with males of other lines, with the
exception of strains in which the target transgene for over-expression was on
the X chromosome. Life span assays consisted of ~25 flies per vial, and a total
5 vials for each cohort. For survival assays performed at 25oC,
flies were transferred to new vials ever other day. For survival assays
preformed at 29oC flies were transferred to new vials every other
day during the first 30-40 days, and then every day for the remainder of the
life span. RU486 (Mifepristone, Sigma) was dissolved in ethanol (100%) to make
a stock solution of 3.2mg/ml. For adult feeding, 50ul RU486 stock solution was
added to the surface of each vial to produce a final concentration of
~160ug/ml; 50ul ethanol was added to the control vials. For larval feeding,
0.5ml of 3.2mg/ml RU486 stock solution (or the indicated diluted concentration)
was added to the surface of each bottle to produce a final concentration of
~160ug/ml (or indicated diluted concentration); 0.5ml ethanol was added to
control bottles.


GeneSwitch driver characterization
. Adult
flies were cultured in vials in the presence and absence of drug for two weeks
prior to dissection. Adult male and female flies, head in half, body in half,
midgut and hindgut, ovary and testes, were photographed. Larvae at 1st instar, 2nd instar and 3rd instar, as well as 3rd instar dissected tissues (brain, midgut and hindgut, salivary gland, imaginal
discs, and fat body) were also photographed. The Leica MZ FLIII fluorescence
stereomicroscope together with the SPOT software were used for photographs: The
GFP pictures were taken under the fluorescent light with exposure time 4 sec
and a gain of 2.


Statistical analysis.
Mean, standard deviation,
median, percent change in mean, percent change in median, and log rank p value were calculated using R 2.6.2 [58 ]. Analysis of mortality rate was
performed with the WinModest statistical package [59 ]. In the
Gompertz-Makeham model, the increaseof mortality (μx )
with age (x) is expressed as: μx= aebx+c,
where the constant a is the initial mortalityrate, b is the rate of exponential increase in mortality, and c is the
age-independent mortality. The age specific mortality rate (μx)
was calculated using WinModest by binning the days over which deaths
were counted (since fly deaths were recorded every other day) such that μx = (-ln(Nx + δx / Nx )) / δx(or Px = Nx + δx / Nx and μx = -1/δx ln(Px )), where Nxis the number of flies alive at day x and δx is the bin size [2 (link)].
Parameters (a, b, c) were also calculated based on a likelihood ratio
test. The full model (aebx+c) was plotted, and the
Gompertz-only component (aebx) was used to build the
decomposed survival curves, using μx: μx= aebx, Px= ex.
For the decomposed survival curves, any value below 0.5% survival was
considered to be the final data point.


Full text: Click here
Publication 2009
Adult Biological Assay Brain Diptera Dissection DNA, Complementary Drosophila Ethanol Fat Body Females Fluorescence Head Human Body Imaginal Discs Larva Light Males Mifepristone Ovary Pharmaceutical Preparations R-38486 Salivary Glands Strains Testis Tissues Transgenes X Chromosome
All mice used in these studies were on the C57BL/6 background. C57BL/6 mice were purchased from The National Cancer Institute (Frederick, MD) or The Jackson Laboratory (Bar Harbor, MN). OTI T cell receptor transgenic mice42 (link), Math1fl/fl mice13 (link), Math1PGRCre mice43 (link), CD11cYFP transgenic mice20 (link), CX3CR1GFP mice44 (link), and ROSAdtomato mice45 (link), mice were purchased from The Jackson Laboratory. Myd88−/− mice46 (link), a gift from Dr. Akira (Osaka University, Osaka, Japan), were bred onto the C57BL/6 background by the Speed Congenics Facility of the Rheumatic Diseases Core Center, and maintained in house. Transgenic mice bearing a tamoxifen-dependent Cre recombinase expressed under the control of the villin promoter (vil-Cre-ERT2) mice 47 (link) were a gift from Sylvie Robine (Institut Curie, Paris, France). Math1fl/fl mice were bred to vil-Cre-ERT2 mice to generate mice with inducible depletion of GCs following deletion of Math1 in villin expressing cells, referred to as Math1iΔvil mice. To deplete GCs, Math1iΔvil mice mice were injected with 100 µg tamoxifen (Sigma-Aldrich, St. Louis, MO, USA) dissolved in sunflower seed oil with 20% ethanol (Sigma-Aldrich) i.p. daily for 4 days. Three days after the final injection, mice were placed on antibiotics for one week and then analyzed for GAP formation by two-photon as described below. Colon tissue was sectioned and stained for goblet cells with alcian blue to ensure goblet cells were knocked out. To generate Math1 reporter mice, Math1PGRCre mice, which express a progesterone inducible Cre under the control of the Math1 locus, were bred with ROSAdtomato mice, referred to as dtomiMath1 mice. To label colonic GCs, dtomiMath1 mice were injected with 200 µg RU486 (mifepristone, Caymen Chemicals, Ann Arbor, MI, USA) dissolved in sesame oil (Acros Organics, Sigma-Aldrich) i.p. every day for 7 days. To delete Myd88 signaling from GCs, Myd88fl/fl mice were bred to Math1PGRcre mice, referred to as to Myd88iΔMath1 mice. To induce deletion of Myd88 in GCs, Myd88iΔMath1 mice were injected with 200 µg RU486 i.p. on day 0 and day 2, and analyzed on day 4. Myd88fl/fl Math1WT littermate mice injected with RU486 were used for controls. Gnotobiotic mice were obtained from the Washington University Digestive Disease Research Core Center murine models core. Animals, other than gnotobiotic mice, were housed in a specific-pathogen-free facility and fed routine chow diet. In some experiments mice were treated with a combination of antibiotics (Abx); ampicillin (1 g/L), metronidazole (1 g/L), neomycin (1 g/L), and vancomycin (500 mg/L) in drinking water for 10 days. Animals were 6 to 16 weeks of age at the time of analysis. Animal procedures and protocols were carried out in accordance with the institutional review board at Washington University School of Medicine.
Publication 2014
Alcian Blue Ampicillin Animals Animals, Transgenic Antibiotics Cells Colon Cre recombinase Deletion Mutation Diet Digestive System Disorders Ethanol Ethics Committees, Research Goblet Cells Metronidazole Mice, House Mice, Inbred C57BL Mice, Laboratory Mice, Transgenic Mifepristone mitogen-activated protein kinase 3, human Mus Neomycin Oil, Sunflower Progesterone R-38486 Rheumatism Sesame Oil Specific Pathogen Free T-Cell Receptor Tamoxifen Tissues Vancomycin villin

Most recents protocols related to «Mifepristone»

Example 4

TABLE 15
Composition of mifepristone tablet 240 mg
Composition H
Ingredientsmg/unit
Mifepristone nano-suspension
Mifepristone240.00
HPMC20.00
Sodium lauryl sulphate6.40
Docusate sodium0.80
Purified waterQ.S.
Intra-granular material
Silicified microcrystalline cellulose280.40
Sodium starch glycolate27.20
Extra-granular material
Microcrystalline cellulose119.6
Sodium starch glycolate20.40
Colloidal silicon dioxide1.8
Magnesium Stearate3.40
Core tablet weight (mg)720.00
Film-coating blend
OPADRY ® II Complete Film Coating21.60
System 85F18422 white
Purified WaterQ.S.
Coated Tablet Weight (mg)741.60
Manufacturing Procedure of Composition H:

Composition H was manufactured according to the following procedure:

  • a) Specified amount of purified water was taken in a suitable container and specified quantity of docusate sodium was added and stirred continuously to obtain a solution.
  • b) Sodium lauryl sulphate was added to the step (a) solution and stirred continuously to obtain a solution.
  • c) Hydroxypropyl methyl cellulose was added to the step (b) solution and stirred continuously to obtain a solution.
  • d) Mifepristone was added to the step (c) solution and stirred for 5 minutes to obtain Mifepristone dispersion.
  • e) Mifepristone dispersion was homogenized using IKA's Ultra TURRAX® homogenizer at 1000 RPM for 15 minutes.
  • f) The above homogenized mifepristone slurry was nano-sized in ball-mill chamber to obtain nano-suspension containing desired particle size of mifepristone. The particle size distribution was measured by using Mastersizer 3000 particle analyser.
  • g) Specified quantities of the silicified microcrystalline cellulose and sodium starch glycolate were dispensed in a bowl and warmed to reach 28° C. to 30° C. temperature.
  • h) The nano-sized mifepristone suspension according to step (f) was sprayed onto the warmed intra-granular material according to step (g). The sprayed granules were dried at a temperature of 50° C. to 65° C. and sieved through 30 number mesh sieve.
  • i) Specified quantities of milled granules of step (h), sodium starch glycolate, microcrystalline cellulose, colloidal silicon dioxide and magnesium stearate were blended and compressed using tablet compression machine. The tablets according to step (i) were coated with suitable coating materials.

Full text: Click here
Patent 2024
Cytoplasmic Granules Docusate Sodium Hypromellose magnesium stearate microcrystalline cellulose Mifepristone Pharmaceutical Preparations Silicon Silicon Dioxide sodium starch glycolate Sulfate, Sodium Dodecyl

Example 5

Particle Size Distribution of Mifepristone Nano-Suspensions Used in Composition G and H:

TABLE 16
Process parameters of nano-milling for preparation of mifepristone
nano-suspensions used in composition G and H:
Nano-suspensionNano-suspension
used inused in
Parameterscomposition Gcomposition H
Mifepristone slurry20%20%
initial solid content
After rinsing of container15%15.8%  
bottle and mill
Due to additionalNA14.1%  
0.1 mm beads rinsing
Size of beads used 0.3 mm0.3 mm and 0.1 mm
Screen0.13 mm0.13 mm and 0.03 mm
Occupancy65%65%
Nano milling time90 minutes with 0.360 minutes with 0.3
mm beadsmm beads and
80 minutes with 0.1
mm beads
Particle Size Distribution (PSD) of mifepristone (in microns)
D100.0900.0602
D500.1860.122
D900.3690.233

TABLE 17
Effect of storage time on particle size distribution
of mifepristone in composition G
Particle Size Distribution (PSD) (in microns)
PSDInitialDay 1Day 3Day 7Day 15
D100.2840.2880.2700.2670.277
D500.3970.4040.3960.3940.404
D900.5490.5610.5830.5840.597

Full text: Click here
Patent 2024
Mifepristone Pharmacy Distribution
All animals (n = 101) were treated with a modified Ovsynch program [1st GnRH, (400 μg, intramuscular (IM); Ningbo Sansheng Pharmaceutical (NSP), China) at day −10, PGF2α (0.5 mg, IM; NSP) on the −3 day, 2nd GnRH injection (200 μg) and mifepristone (0.4 mg/kg BW, IM, Hubei Yun Cheng Sai Technology, China) on day −1, AI after 24 h of the 2nd GnRH using frozen-thawed semen and 3rd GnRH on the day 5th day of AI; Figure 1]. Ultrasonography (Desktop B-type veterinary ultrasound scanner, WED-9618-v, LV2-3/6.5 MHz rectal probe; Shenzhen Well D Medical Electronics, Guangdong, China) was used to monitor follicle development (from the day before PGF2α treatment until 72 h of the 2nd injection of GnRH), CL dynamics (at day 20 and 21 of AI). Prior to AI, the buffaloes were also monitored for estrus signs (vaginal mucous discharge, bellowing, milling, swollen vagina, and head butting) twice daily (06:00 and 18:00). Buffaloes were also observed for estrus signs between days 18 to 24 of AI to record the non-return rate in synchronized buffaloes.
The experimental buffaloes were further divided into four groups (GnRH-0; n = 26, GnRH-100; n = 22, GnRH-150; n = 25 and GnRH-200; n = 28) according to the dose of 4th GnRH injection (0, 100, 150, and 200 μg) at day 20 of AI. The buffaloes were monitored for pregnancy losses at day 30, 40, 60, and 90 days after AI using ultrasonography. Milk samples were collected at day 20 of AI for milk P4 level (Quanzhou Ruixin Biological Technology Co., LTD) to predict the pregnancy in synchronized buffaloes. In addition, blood samples were obtained from synchronized buffaloes at days 20, 40, and 60 to observe deviation in the P4 level of buffaloes with pregnancy or embryonic loss.
Full text: Click here
Publication 2023
Animals Biopharmaceuticals BLOOD Buffaloes Dinoprost Embryo Loss Estrus Frozen Semen Gonadorelin Head Mifepristone Milk Mucus Ovarian Follicle Pharmaceutical Preparations Pregnancy Rectum Ultrasonics Ultrasonography Vagina
The expression pattern seen in the late third- instar in stable spilt lines was maintained through metamorphosis using the flip-switch method described in Harris et al., 2015 (link). Using a similar strategy of the gene-switch method (Roman et al., 2001 (link)), flippase was fused to the ligand-binding domain of the human progesterone receptor, rendering it dependent on progesterone or a progesterone mimic to move into the nucleus. Stable split lines were crossed to pJFRC48-13XLexAop2-IVS-myrtdTomato in su(Hw)attP8; Actin5Cp4.6>dsFRT>LexAp65 in su(Hw)attP5; pJFRC108-20XUAS-IVS-hPRFlp-p10 in VK00005/TM6.
We used the progesterone mimic mifepristone (RU486, Sigma-Aldrich; #M8046) to cause translocation of the flippase to the nucleus where it could then flip-out the STOP cassette in the Actin-LexAp65 transgene. We used surface application of RU486 to food vials. Parents were allowed to lay eggs in a food vial for a few days, then transferred to a fresh vial. Approximately 4 days after transfer, 60 μl of an ~10 mM RU486 stock solution (10 mg RU486 dissolved in 2 ml 95% ethanol) was applied to the surface of the food. At 24 hr after treatment, any larvae that had wandered and/or pupariated were discarded to ensure that test animals had fed on RU486 for at least 24 hr. At 48 hr after treatment, the subsequent wandering larvae and pupae (which had all fed on RU486 for 24–48 hr during the L3 stage) were collected and transferred to an untreated food vial. These animals were then dissected in Schneider’s S2 culture medium as adults. This treatment results in constitutive LexA expression in any cells that express GAL4 during the L3 stage, but, because the RU486 persists at least partway through metamorphosis, neurons that start expressing in early to mid-metamorphosis also show up.
Full text: Click here
Publication 2023
Actins Adult Aftercare Animals Biological Metamorphosis Cell Nucleus Cells Culture Media Eggs Ethanol Food Homo sapiens Larva Ligands Mifepristone Neurons Parent Progesterone Pupa R-38486 Receptors, Progesterone Transgenes Translocation, Chromosomal Vision
Flies were maintained at 25 °C, 60% relative humidity, and 12-h light/dark cycle. Adults and larvae were reared on a standard cornmeal and yeast-based diet, unless otherwise noted. The Gal4/UAS driven RNAi crosses were cultured at 25°C until eclosion, and then incubated at 29°C for 7 days, and the same culture conditions were also used for the control group.
promE-Gal4 and promE-GS-Gal4 (oeno-specific GAL4) were obtained from Dr. H. Bai(92 ). UAS-fruMA and UAS-fruCOMB were from Dr. M. Arbeitman. elav-Gal4 (BDSC#6920), UAS-fruRNAi (BDSC#31593), UAS-GFP (BDSC#5413), fru-NP21-Gal4 (BDSC# 30027), fru-P1-Gal4 (BDSC#66696), Hnf4::GFP.FLAG (BDSC#38649), UAS-Hnf4RNAi (BDSC#29375), UAS-Hnf4RNAi (BDSC#64988), UAS-dsxRNAi (BDSC#55646), Act5C-GAL4 (BDSC#4414) and W1118 (BDSC#5905) were obtained from the Bloomington Drosophila Stock Center. UAS-fru-gRNA (VDRC#342548), UAS-fruRNAi (VDRC#330035), UAS-fruRNAi (VDRC#105005) were obtained from the Vienna Drosophila Resource Center. UAS-Hnf4::HA (F000144) was obtained from FlyORF (Zurich ORFeome Project).
RU486 (mifepristone, Fisher Scientific) was dissolved in 95% ethanol, and added to standard food at a final concentration of 100 μM for all the experiments. For activation of the GeneSwitch (GS) Gal4 driver, flies were fed on RU486 food for 7 consecutive days, unless otherwise noted.
To temporally induce fru MAGIC clones, early 3rd instar larvae of w; UAS-frug-RNA/Act5C-Gal4; HS-Cas9/+ were heat shocked for 30min at 37°C, and examined at day-7 after eclosion. The HS-Cas9 stock was kindly provided by Dr. C. Han(42 (link)).
Publication Preprint 2023
Adult Clone Cells Diet Diptera Drosophila Ethanol Food Humidity Larva Mifepristone R-38486 RNA Interference Yeast, Dried

Top products related to «Mifepristone»

Sourced in United States, Germany, United Kingdom, Sao Tome and Principe, Canada
Mifepristone is a synthetic steroid compound developed by the Roussel Uclaf pharmaceutical company, which was later acquired by Merck Group. It functions as a progesterone receptor antagonist, blocking the action of the natural hormone progesterone.
Sourced in United States, Germany, United Kingdom, China, Japan, Italy, Sao Tome and Principe, Macao, France, Australia, Switzerland, Canada, Denmark, Spain, Israel, Belgium, Ireland, Morocco, Brazil, Netherlands, Sweden, New Zealand, Austria, Czechia, Senegal, Poland, India, Portugal
Dexamethasone is a synthetic glucocorticoid medication used in a variety of medical applications. It is primarily used as an anti-inflammatory and immunosuppressant agent.
Sourced in United States, Germany, United Kingdom, Israel, Canada
RU486 is a laboratory product manufactured by Merck Group. It is a synthetic steroid compound used for research purposes. The core function of RU486 is to act as an antiprogesterone agent.
Sourced in United States, Sao Tome and Principe
Mifepristone (RU486) is a synthetic steroid compound that acts as an antiprogesterone agent. It is primarily used as a pharmaceutical ingredient in medical procedures.
Sourced in United States
Mifepristone is a synthetic steroid compound used as a pharmaceutical ingredient in laboratory research. It functions as an anti-progestogen, binding to and blocking the progesterone receptor. Mifepristone is commonly used in studies involving reproductive biology, endocrinology, and pharmacology.
Sourced in United States, Germany, United Kingdom, China, Italy, Sao Tome and Principe, France, Macao, India, Canada, Switzerland, Japan, Australia, Spain, Poland, Belgium, Brazil, Czechia, Portugal, Austria, Denmark, Israel, Sweden, Ireland, Hungary, Mexico, Netherlands, Singapore, Indonesia, Slovakia, Cameroon, Norway, Thailand, Chile, Finland, Malaysia, Latvia, New Zealand, Hong Kong, Pakistan, Uruguay, Bangladesh
DMSO is a versatile organic solvent commonly used in laboratory settings. It has a high boiling point, low viscosity, and the ability to dissolve a wide range of polar and non-polar compounds. DMSO's core function is as a solvent, allowing for the effective dissolution and handling of various chemical substances during research and experimentation.
Sourced in United States, Germany, United Kingdom, Canada, France, Sao Tome and Principe, Macao, Japan, Italy, Brazil, China, Netherlands
Progesterone is a steroid hormone that plays a crucial role in the female reproductive system. It is a key component in the regulation of the menstrual cycle and supports the maintenance of pregnancy. Progesterone is commonly used in various lab equipment and scientific research applications.
Sourced in United States, Germany, France, United Kingdom
Spironolactone is a potassium-sparing diuretic medication manufactured by Merck Group. It is a synthetic steroid compound that inhibits the actions of aldosterone, a hormone involved in the regulation of blood pressure and fluid balance. Spironolactone is used to treat conditions such as heart failure, high blood pressure, and fluid retention.
Sourced in United States, China, United Kingdom, Germany, Australia, Japan, Canada, Italy, France, Switzerland, New Zealand, Brazil, Belgium, India, Spain, Israel, Austria, Poland, Ireland, Sweden, Macao, Netherlands, Denmark, Cameroon, Singapore, Portugal, Argentina, Holy See (Vatican City State), Morocco, Uruguay, Mexico, Thailand, Sao Tome and Principe, Hungary, Panama, Hong Kong, Norway, United Arab Emirates, Czechia, Russian Federation, Chile, Moldova, Republic of, Gabon, Palestine, State of, Saudi Arabia, Senegal
Fetal Bovine Serum (FBS) is a cell culture supplement derived from the blood of bovine fetuses. FBS provides a source of proteins, growth factors, and other components that support the growth and maintenance of various cell types in in vitro cell culture applications.
Sourced in United States, China, United Kingdom, Germany, Italy, France, Sao Tome and Principe
Corticosterone is a laboratory reagent used in scientific research. It is a naturally occurring steroid hormone produced by the adrenal glands in various species. Corticosterone plays a role in the regulation of metabolism, immune function, and stress response. As a research tool, it is often utilized in studies involving endocrinology, neuroscience, and pharmacology.

More about "Mifepristone"

Mifepristone, also known as RU486, is a synthetic steroid compound that acts as an antiprogesterone agent.
It is widely used for the termination of early pregnancy, as well as for other medical applications such as the treatment of Cushing's syndrome.
Mifepristone works by binding to the progesterone receptor and blocking the action of the natural hormone progesterone, resulting in the disruption of early pregnancy development.
Mifepristone research is an important area of study, and researchers often utilize various related compounds and techniques to enhance their investigations.
Dexamethasone, for example, is a synthetic glucocorticoid that can be used in combination with Mifepristone to study its effects on Cushing's syndrome.
Similarly, DMSO (Dimethyl Sulfoxide) is a versatile solvent that can be used to dissolve Mifepristone for various experimental purposes.
Progesterone, the natural hormone that Mifepristone antagonizes, is another key component in Mifepristone research.
Spironolactone, a diuretic drug, can also be studied in relation to Mifepristone due to its ability to block the effects of progesterone.
Additionally, fetal bovine serum (FBS) is often used as a culture medium in Mifepristone studies, while Corticosterone, a stress hormone, can be investigated in relation to Mifepristone's effects on Cushing's syndrome.
PubCompare.ai, a leading AI-driven platform, can help optimize your Mifepristone research by providing easy access to protocols from literature, pre-prints, and patents, as well as AI-driven comparisons to identify the best protocols and products.
This can enhance the reproducibility and accuracy of your Mifepristone studies, allowing you to make more informed decisions and progress your research more effectively.